A Potent Glucose–Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells
Open Access
- 8 January 2016
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 128 (7) , 2596-2600
Abstract
Three rationally designed glucose–platinum conjugates (Glc–Pts) were synthesized and their biological activities evaluated. The Glc–Pts, 1–3, exhibit high levels of cytotoxicity toward a panel of cancer cells. The subcellular target and cellular uptake mechanism of the Glc–Pts were elucidated. For uptake into cells, Glc–Pt 1 exploits both glucose and organic cation transporters, both widely overexpressed in cancer. Compound 1 preferentially accumulates in and annihilates cancer, compared to normal epithelial, cells in vitro.Keywords
Funding Information
- NCI (CA034992)
This publication has 41 references indexed in Scilit:
- Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose MetabolismPLOS Computational Biology, 2012
- Visualizing Sweetness: Increasingly Diverse Applications for Fluorescent-Tagged Glucose Bioprobes and Their Recent Structural ModificationsSensors, 2012
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)British Journal of Pharmacology, 2010
- Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer TherapyInternational Journal of Endocrinology, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Organic Cation Transporters Are Determinants of Oxaliplatin CytotoxicityCancer Research, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- On the Origin of Cancer CellsScience, 1956